Lung Cancer Awareness Month: Small Cell vs. Non-Small Cell Cancer

November is honored as Lung Cancer Awareness Month. As the second-most commonly diagnosed disease in men and women, lung cancer can be a scary and difficult disease to understand. Here’s what you need to know about the two types of lung cancer:

Non-small cell lung cancer (NSCLC) accounts for 80-85 percent of diagnosed cases of lung cancer and grows at a slower rate than small cell lung cancer, according to the Lung Cancer Alliance. NSCLC can come in different forms depending on the initial location of the disease. These types include adenocarcinoma, which begins in the lining of the lungs, and squamous cell carcinoma, which begins in the passages of the respiratory tract.

Small cell lung cancer (SCLC) is a less common form of the disease and is characterized by cells that are smaller in size than most other cancer cells. The disease forms in the tissue of the lungs and can spread rapidly to other parts of the body. This form of lung cancer can be more difficult to treat and smokers are the most at risk.

CyberKnife Center of Chicago treats both forms of lung cancer and metastatic lung cancer using CyberKnife® technology. Patients are treated noninvasively within five outpatient sessions and typically return to their routines immediately following treatment. For more information on how CyberKnife targets tumors in the lung, visit our website.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.